Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

CYP2A6

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Cytochrome P450 family 2 subfamily A member 6 (CYP2A6) plays a unique role among all P450 enzymes in the liver that are involved in drug metabolism. Compared with other P450 family enzymes, this membrane-bound heme enzyme processes a far smaller range of substrates. Yet among the limited set of substances it can metabolize is an alkaloid with extremely high global consumption, which makes CYP2A6 the core enzyme responsible for eliminating this substance from the body. Every complete catalytic cycle it undergoes follows the conserved catalytic logic shared by all P450 enzymes: at its core lies an iron-carrying heme group anchored by a fixed cysteine thiolate; its partner reductase sequentially delivers electrons to it; the active site is shaped by surrounding helical structures that are precisely sized to screen for small, flat molecules containing nitrogen atoms, completing the full metabolic process. CYP2A6 functions primarily in hepatocytes of the liver. Beyond this main site of action, its presence can also be detected in several barrier tissues, where its measured expression levels are sufficient to support its corresponding physiological roles. Among all human enzymes involved in drug metabolism, its interindividual activity variation is among the largest. This extreme variability is the core driving force behind the academic community's sustained research into CYP2A6. Numerous factors contribute to this variability: gene deletions, base substitutions that completely abolish enzyme activity, and changes in gene copy number combine to create an extremely wide activity span: some individuals almost entirely lose the enzyme's function, with their metabolic activity nearly undetectable, while others have an unusually rapid metabolic turnover rate that far exceeds normal levels.

Fig. Potential inhibition of CYP2A6-mediated metabolism. (OA Literature)Fig.1 Schematic of nicotine metabolic pathways showing potential inhibition of CYP2A6-mediated metabolism.1

CYP2A6 in Action: Narrow Substrates, Wide Consequences

A handful of research threads keep this enzyme busy:

  • A Diagnostic Oxidation Reaction: The hydroxylation of a simple lactone substrate serves as the standard readout for detecting CYP2A6 activity. It has sufficient specificity to be universally applicable in population studies of all types, and its operation is simple enough to complete quantification without complex analytical workflows. This convenient diagnostic property has firmly established this enzyme's value as a basic research tool.
  • The Variation Spectrum as an Experimental Asset: Innate variations including gene deletions, inactivating mutations, and gene duplications create naturally occurring, wide-ranging differences in metabolic capacity across human populations. Scientists leverage this span of variability to study how enzyme levels influence a series of outcomes, from substance clearance efficiency to consumption behaviors—and CYP2A6 can explain this linkage with exceptional clarity, which is uncommon in comparable studies.
  • Inductive Regulation: The expression level of this enzyme changes in response to upstream regulatory signals, and researchers can exploit this characteristic to obtain an adjustable variable for studying how P450 levels are dynamically set and modulated. To this day, research related to Inductive Regulation remains a stable core component of the CYP2A6 research framework.

CYP2A6 Membrane Protein Product List

The CYP2A6 we produce follows iron conditions throughout its generation logic, fully consistent with natural synthesis rules. The full-length CYP2A6 we obtain is developed using a specialized optimized expression system, which preserves the native folding state of the natural molecule throughout the production process. Even the various post-translational modification features added after synthesis are identical to those that form naturally within organisms. For every batch of products shipped, a complete factory release test report is included, and the contents of the report are all verifiable test results: purity data measured via the SDS-PAGE method, and monodispersity data measured via analytical-grade size-exclusion chromatography, which proves that the molecules in the product exist in a uniform single state and will not aggregate into clumps that affect usage. The Membrane Protein Product of CYP2A6 we launch does not have fixed, rigid specifications. If you have specific research requirements, whether you need to adjust any parameters or modify any details, you may put forward your requests. We can specially design, adjust and even modify the product according to your requirements, and meet all kinds of research needs in your laboratory.

CYP2A6 Membrane Protein Product List

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

CYP2A6 Stable Cell Line Product List

Expression level is the core variable that determines the final output of cellular metabolism. If this parameter is ambiguous, subsequent experimental data cannot be clarified at all. Therefore, when we construct cell models for CYP2A6 research, we build all of them in accordance with clear standardized tiers, and never use unstandardized, ambiguous descriptions such as "high expression" to mislead users. Every cell clone undergoes a complete set of characterization tests before being delivered to you: the expression level of CYP2A6 is first quantified and calibrated, its subcellular localization is fully documented, and finally its catalytic activity is verified to be normal. By the time you receive the cell line and prepare to start your own experiments, you will already have a thorough understanding of its metabolic behaviors, and will never encounter a situation where unclear parameters render it unusable after you receive it.

CYP2A6 Stable Cell Line Product List

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

CYP2A6 Recombinant Antibody Product List

Within the CYP family, the members of the 2A subfamily share particularly close genetic relationships and high sequence similarity. If the antibody clone used for detection cannot distinguish between these closely related members, unintended cross-reactivity will occur. This mismatching often goes undetected in time, and by the time you notice an abnormality, the quantitative detection results will have long been invalidated due to errors. The recombinant antibody portfolio we offer first passes a screening stage to ensure every product can specifically recognize CYP2A6 without confusion with other members of the subfamily; after passing the screening stage, it undergoes three additional rounds of validation, covering the scenarios of quantitative detection of cell lysates, distribution mapping of fixed samples, and imaging-based detection, ensuring stable performance across all commonly used research scenarios. When characterizing each antibody clone, we use sample types that researchers actually use in routine work, and never fill requirements with rare, specialized samples. Furthermore, all production follows clear sequence standards. Even if your research project spans several years, the performance of antibodies purchased from different batches will remain consistently stable, so you will never encounter a situation where the effect of one batch differs from the previous one, which could delay your long-term research progress.

CYP2A6 Recombinant Antibody Product List

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • High Purity & Activity: High purity and verified integrity for dependable downstream work.
  • Diverse Expression Systems: Choice of expression formats to match routine or specialized projects.
  • Species Reactivity: Products available for human, mouse, pig, and other species.
  • Validated Applications: Application-tested to deliver consistent signals across common lab workflows.
  • Exceptional Lot-to-Lot Consistency: Tight lot-to-lot control for reproducible performance.
  • Customization Options: Flexible customization of tags, labels, or packaging upon request.

Custom CYP2A6 Membrane Protein and Antibody Discovery Services

Extending well beyond our standard catalog, we deliver fully customizable discovery and manufacturing solutions meticulously tailored to the sophisticated demands of CYP2A6-targeted research and precompound development:

  • Custom CYP2A6 Protein Production: Tailored expression, purification, and characterization of challenging multi-domain receptor constructs.
  • Custom Antibody Development: From antigen design to antibody engineering (monoclonal, polyclonal, recombinant) for specific research applications.
  • Stable Cell Line Development: Generation of bespoke stable cell lines expressing your target of interest.
  • Functional Assay Development: Designing and executing assays to assess receptor activation and ligand.

Frequently Asked Questions (FAQ)

  1. What should I include in a first inquiry?

    A brief description of the application, the format envisioned, and any acceptance criteria already in mind is sufficient. Technical details can be refined together from there.

  2. How do I choose between a catalog product and a custom service?

    Catalog items cover standard detection or activity workflows well. Custom production earns its place when constructs, formats, or quality attributes step beyond routine specifications. A short consultation is usually enough to decide.

  3. Can special formats or combined protein, cell line, and antibody projects be handled together?

    Yes. Custom formats and integrated multi-component engagements are routine, with unified quality frameworks keeping specifications aligned.

  4. What is the intended use scope of these reagents and services?

    All CYP2A6 products and services are provided strictly for preclinical research. They are not designed, validated, or authorized for any use involving human subjects.

Reference
  1. Olawale, Margaret E., and Philip Lazarus. "Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy." The Journal of Pharmacology and Experimental Therapeutics (2025): 103792. Under Open Access license CC BY 4.0, without modification.https://doi.org/10.1016/j.jpet.2025.103792
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;